Clinical Trials Logo

Vomiting clinical trials

View clinical trials related to Vomiting.

Filter by:

NCT ID: NCT00310063 Completed - Clinical trials for Unspecified Childhood Solid Tumor, Protocol Specific

Acupressure in Preventing Nausea and Vomiting in Young Cancer Patients Receiving Chemotherapy

Start date: April 2005
Phase: N/A
Study type: Interventional

RATIONALE: Using acupressure wrist bands to press and stimulate nerves at an acupressure point on the inside of the wrist may help control nausea and vomiting caused by chemotherapy. PURPOSE: This randomized clinical trial is studying how well acupressure works in preventing nausea and vomiting in young cancer patients receiving chemotherapy.

NCT ID: NCT00306735 Completed - Multiple Myeloma Clinical Trials

Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation.

Start date: March 2006
Phase: Phase 2
Study type: Interventional

The primary purpose of this study is to explore the efficacy of three different dose schedules of palonosetron for the prevention of emesis over a 7-day study interval in multiple myeloma patients.

NCT ID: NCT00293644 Completed - Pregnancy Clinical Trials

Pre-emptive Treatment of Severe Nausea and Vomiting of Pregnancy

Start date: February 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether pre-emptive use of a delayed release combination of pyridoxine hydrochloride and doxylamine succinate (Diclectin®), before eruption of symptoms of Nausea and vomiting of pregnancy and hyperemesis gravidarum, will reduce the incidence of severe forms of this syndrome/HG.

NCT ID: NCT00293618 Completed - Clinical trials for Postoperative Nausea and Vomiting

Implementation Study of the PostOperative Nausea and Vomiting Prediction Rule

Start date: March 2006
Phase: N/A
Study type: Interventional

This study evaluates whether the implementation of a prediction rule for postoperative nausea and vomiting changes physician behaviour, improves patient outcome and improves cost-effectiveness of treatment of postoperative nausea and vomiting.

NCT ID: NCT00293384 Completed - Breast Cancer Clinical Trials

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

Start date: October 2004
Phase: N/A
Study type: Interventional

RATIONALE: Antiemetic drugs, such as aprepitant, granisetron, and dexamethasone, may help lessen or prevent nausea and vomiting in patients treated with chemotherapy. PURPOSE: This clinical trial is studying how well giving aprepitant together with granisetron and dexamethasone works in preventing nausea and vomiting in patients receiving cyclophosphamide before undergoing an autologous stem cell transplant.

NCT ID: NCT00286988 Terminated - Vomiting Clinical Trials

Topiramate for the Prophylactic Treatment of Cyclic Vomiting Syndrome in Children

Start date: March 2006
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the effectiveness, tolerability and safety of oral topiramate for the preventative management of Cyclic Vomiting Syndrome. It is believed that topiramate will decrease the frequency, duration and severity of attacks experienced by children and adolescents with Cyclic Vomiting Syndrome.

NCT ID: NCT00275483 Completed - Clinical trials for Postoperative Nausea and Vomiting

Prevention of Postoperative Nausea and Vomiting (PONV) by Acupressure

Start date: May 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether stimulation to the akupressurpoint P6 with a recently developed bracelet are effective preventing postoperative nausea and vomiting

NCT ID: NCT00274690 Completed - Clinical trials for Postoperative Nausea and Vomiting

Post-Operative Nausea And Vomiting Study In Female Patients

Start date: February 2005
Phase: Phase 2
Study type: Interventional

The primary purpose of this study is to determine an effective dose of this NK-1 anti-emetic medication to prevent nausea and vomiting in females after surgery.

NCT ID: NCT00273468 Completed - Clinical trials for Chemotherapy-induced Nausea and Vomiting

To Study the Safety and Effectiveness of a Granisetron Patch to Treat Chemotherapy-Induced Nausea and Vomiting (CINV)

Start date: January 2006
Phase: Phase 3
Study type: Interventional

To study the safety and effectiveness of a granisetron patch to treat Chemotherapy-Induced Nausea and Vomiting (CINV)

NCT ID: NCT00272285 Completed - Nausea Clinical Trials

A Study of Ramosetron Plus DX, Dexamethasone, Compared to Granisetron Plus DX for the Prevention of Vomiting and Nausea

Start date: January 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy and safety of ramosetron plus dexamethasone injection with granisetron plus dexamethasone injection for the prevention of chemotherapy-induced vomiting and nausea.